Zecotek’s Chairman Dr. A.F. Zerrouk to Speak at the InfoComm Projection Summit 2011 in Orlando, Florida
Singapore, June 1, 2011 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets today announced that Dr. A.F. Zerrouk, the Company’s Chairman, President, and CEO will participate as a guest speaker at the InfoComm Projection Summit 2011 in Orlando, Florida on June 13. This is the tenth annual Projection Summit, one of the world’s premier IT events, which is expected to attract over 28,000 attendees from more than 70 countries. It is an executive-level conference where leaders of industry and media to learn about the key trends and issues shaping the professional audio visual industry and consumer markets. Dr. Zerrouk will be presenting on Zecotek’s glasses-free 3D Display System in a key note session on auto-stereoscopic displays.
“I am honoured to have been invited as a guest speaker for this year’s prestigious Projection Summit to talk about Zecotek’s patented glasses-free 3D display system,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “Our auto-Auto-stereoscopic 3D display does not require viewers to wear glasses. The 3D effect is produced using the widest possible number of views as it offers a natural viewing experience when compared to systems currently offered for 3D television and other consumer based monitors. As such, this patented technology presents a potential breakthrough technology for the wider use of 3D in a variety of industrial, scientific, commercial and security applications.”
The Projection Summit is held in conjunction with InfoComm and features invited speakers from leading technology developers, market research firms and major brands covering the display industry. Sessions are organized to produce thought provoking presentations with question and answer time to facilitate understanding of the key drivers that will shape the future.
As previously announced Zecotek was granted patent number 7,944,465 by the U.S. Patent and Trademark Office for its glasses-free auto-stereoscopic 3D display system. Patents have now been granted to Zecotek for its 3D display system in the United States and Australia with additional patents pending in Japan, China, Korea, India, Russia and major countries in Europe.
-30-
About the Projection Summit Conference
Business, marketing, and technology leaders from all levels of the big screen display value chain gather once a year at the annual Projection Summit Conference. The Summit provides a unique opportunity to learn about the technology and market forces that are shaping the ProAV and consumer markets. The executive-level conference allows attendees to hear from and engage with the industry’s movers and shakers. The stimulating sessions and discussion will focus on key industry trends and issues – matters that will affect business decisions at all levels of the industry. The event is held in conjunction with InfoComm 2011 in Orlando, FL, USA, June 15-19. For more information, please visit: http://www.projectionsummit.com.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance crystals, photo detectors, medical lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: medical imaging, medical lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending bio-photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
|
Zecotek Photonics Inc. Michael Minder T: (604) 827-5212 [email protected] |
CHF Investor Relations Julia Clark, Account Manager T: (416) 868-1079 x236 [email protected] |
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.